| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/30/2007 | US7169806 Antidiabetic agents |
| 01/30/2007 | US7169805 Captopril derivatives |
| 01/30/2007 | US7169801 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 01/30/2007 | US7169799 Process for producing crystal |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
| 01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/30/2007 | US7169793 An amorphous form of esomeprazole, and dosage forms thereof; enantioselective process involves forming a transition metal complex; treating gastric disorders such as ulcers |
| 01/30/2007 | US7169791 Inhibitors of tyrosine kinases |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169789 Quinoline derivatives and quinazoline derivatives |
| 01/30/2007 | US7169788 controlling signal transduction; angiogenesis inhibitor; anticancer agents; antitumor agents; cardiovascular disorders; vision defects; antiinflammatory agents |
| 01/30/2007 | US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 01/30/2007 | US7169784 Medical devices employing triazine compounds and compositions thereof |
| 01/30/2007 | US7169782 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2007 | US7169781 Such as 2-(2,6-dichlorophenyl)-4-(3-chlorophenyl)-5-(2-methylthiopyrimidin-4-yl)-N H-imidazole as anticarcinogenic agent |
| 01/30/2007 | US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169775 Amino methyl imidazoles as C5a receptor modulators |
| 01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/30/2007 | CA2207628C 3-aryl-1,2,4-triazole derivatives with herbicidal properties |
| 01/29/2007 | CA2554737A1 Compositions and methods for treating cancer and other diseases characterized by abnormal cell proliferation |
| 01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011626A2 Histone deacetylase inhibitors |
| 01/25/2007 | WO2007011623A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | WO2007011618A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | WO2007011417A2 Metallic chromonic compounds |
| 01/25/2007 | WO2007011292A1 N-benzyl-morpholine derivatives as modulators of the chemokine receptor |
| 01/25/2007 | WO2007011290A1 Bronchorelaxing agents based on indol- and isoquinoline derivatives |
| 01/25/2007 | WO2007011022A1 3-(isoquinoline-1-yl)quinoline derivative |
| 01/25/2007 | WO2007010964A1 Indole derivative having pgd2 receptor antagonist activity |
| 01/25/2007 | WO2007010390A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007010217A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS |
| 01/25/2007 | WO2007010144A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | WO2007010044A1 3-indolylmethylene derivatives with cytostatic action |
| 01/25/2007 | WO2007009777A1 Chemical compounds |
| 01/25/2007 | WO2007009774A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 01/25/2007 | WO2007009758A2 2r,4s) -4- (4-acetyl-3-hydroxy-1-piperazinyl) -n- { (1r) -1- [3, 5-bis (trifluoromethyl) phenyl] ethyl} -2- (4-fluoro-2-methylphenyl) -n-methyl-1-piperidine-carboxamide as tachykinin receptor antagonist |
| 01/25/2007 | WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 01/25/2007 | WO2007009717A1 Pyrazole-4- carboxamide derivatives as microbiocides |
| 01/25/2007 | WO2007009688A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 01/25/2007 | WO2007009687A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 01/25/2007 | WO2007009578A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/25/2007 | WO2007009299A1 Optically pure n',n'-di substituted -prolylhydrazines as well as the preparation and use thereof |
| 01/25/2007 | WO2007009250A1 Renin inhibitors |
| 01/25/2007 | WO2007009227A1 Hepatitis c inhibitor peptide analogs |
| 01/25/2007 | WO2006131303A3 Peptide deformylase (pdf) inhibitors 4 |
| 01/25/2007 | WO2006127576A3 N - formyl hydroxylamine compounds as pdf inhibitors |
| 01/25/2007 | WO2006122408A9 Bir domain binding compounds |
| 01/25/2007 | WO2006114415A3 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester |
| 01/25/2007 | WO2006113864A3 Oxindole compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006065277A3 Heterocyclic aspartyl protease inhibitors |
| 01/25/2007 | WO2005025556A3 Antibiotic cycloalkyltetrahydroquinoline derivatives |
| 01/25/2007 | US20070021621 low non-specific binding, photostable, ease of chemical modification to permit tuning of absorption and emission wavelengths and resistance to the formation of dimers; 1-(5-carboxy-pentyl)-2-[5-(1-ethyl-3,3-dimethyl-5-phosphono-1,3-dihydro-indol-2-ylidene)-penta-1,3-dienyl]-3,3-dimethyl-3H-indolium |
| 01/25/2007 | US20070021611 chemokine receptor antagonists used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, skin disorders, diabetes, meningitis and tumors |
| 01/25/2007 | US20070021609 4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 01/25/2007 | US20070021607 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/25/2007 | US20070021489 such as (4-{2-[5-Carbamimidoyl-1-oxo-1,3-dihydro-isoindol-2-yl]-acetyl}-phenoxy)-acetic acid methyl ester, used for inhibiting the binding of fibrinogen to blood platelets, platelet aggregation and for the treatment of thrombotic diseases |
| 01/25/2007 | US20070021482 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/25/2007 | US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
| 01/25/2007 | US20070021468 reacting succinic acid derivatives with substituted hydrazines in presence of acid scavengers and solvents, to form chemical intermediates for benzoxazinones; cyclization |
| 01/25/2007 | US20070021467 Salts of omeprazole and esomeprazole II |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021459 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021436 4-(7-chloro-quinazolin-4-yl)-piperidine; use in the synthesis of protein tyrosine kinase inhibitors, particularly inhibitors of FLT3 and/or c-kit and/or TrkB |
| 01/25/2007 | US20070021424 e.g. 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)-oxy]ethyl}carbamate; fatty acid amide hydrolase inhibitor; cannabinoid and vanilloid receptors blocking agent; analgesic, antiinflammatory, anticarcinogenic, anxiolytic agent, neurodegenerative diseases, antidepressant |
| 01/25/2007 | US20070021419 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 01/25/2007 | US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 01/25/2007 | US20070021410 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070021405 Aryl- and heteroarylpiperidinecarboxylate-derivatives methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021404 Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070020479 Luminescent-polymer composition |
| 01/25/2007 | US20070018155 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 01/25/2007 | DE102005034265A1 New 4-pyrroloisoindolyl-substituted dihydropyridine derivatives, useful as antagonists of the mineralcorticoid receptor for treating e.g. aldosteronism, hypertension and stroke |
| 01/25/2007 | DE102005033103A1 Heterocyclylamid-substituierte Thiazole, Pyrrole und Thiophene Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/25/2007 | CA2615751A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | CA2615588A1 Pyrazole derivatives as cb1 modulators |
| 01/25/2007 | CA2615518A1 Pyrazole-4- carboxamide derivatives as microbiocides |
| 01/25/2007 | CA2615380A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615373A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615105A1 Histone deacetylase inhibitors |
| 01/25/2007 | CA2615049A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/25/2007 | CA2615048A1 Renin inhibitors |
| 01/25/2007 | CA2612469A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1746092A1 Compounds and methods for treatment of amyloid-B-peptide related disorders |
| 01/24/2007 | EP1746087A1 Derivates of 3-indolylmethylene having cytostatic properties |
| 01/24/2007 | EP1746086A1 Cyanopyrrolidine derivatives |
| 01/24/2007 | EP1745042A1 Diarylamine derivatives as calcium channel blockers |
| 01/24/2007 | EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway |
| 01/24/2007 | EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 01/24/2007 | EP1745037A1 Indolylmaleimide derivatives as pkc inhibitors |
| 01/24/2007 | EP1745036A2 Cytokine inhibitors |
| 01/24/2007 | EP1745035A1 Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid-{2-fluoro-5-¬3-((e)-2-pyridin-2-ylvinyl)-1h-indazol-6-ylamino|-phenyl}-amide |